These results indicate that NRF2 binds the promoter of the ERR1 gene as a silencer and inhibits ERR1 gene expression, which may be the underlying mechanism for the upregulation of RhoA in breast cancer cells. This evidence concerns the gene ESRRA and breast carcinoma.